pNaKtide, a Src inhibitor, has been shown to effectively block the Na/K-ATPase oxidant amplification loop, improving the outcome and decreasing risk of a number of diseases associated to oxidative stress such as obesity, steatohepatitis, atherosclerosis, and cancer. The gene discussed is SRC; the disease is obesity disorder.